Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: QNASL

« Back to Dashboard

Summary for Tradename: QNASL

Patents:4
Applicants:1
NDAs:1
Suppliers: see list1

Pharmacology for Tradename: QNASL

Clinical Trials for: QNASL

The Effect of HFA - Beclomethasone Dipropionate Qvar on Bronchial Hyperreactivity in Preschool Children
Status: Completed Condition: Asthma; Bronchial Hyperresponsiveness

Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth
Status: Recruiting Condition: Asthma

Effects of QVAR in Smokers With Asthma
Status: Recruiting Condition: Asthma

Real-world Effectiveness and Cost-effectiveness of Qvar Versus FP, a US Study
Status: Completed Condition: Asthma

A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps
Status: Recruiting Condition: Nasal Polyps

Qvar vs FP in Pediatrics
Status: Completed Condition: Asthma

Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis
Status: Recruiting Condition: Asthma; Allergic Rhinitis

Efficacy of Nebulised Beclometasone in Viral Wheezing Prophylaxis
Status: Completed Condition: Bronchial Spasm; Respiratory Sounds; Respiratory Tract Infections

Fine Particle pMDI Formoterol/Beclomethasone in Asthmatics With and Without Spacer: Comparative Efficacy Evaluation
Status: Recruiting Condition: Asthma

Real-life Effectiveness and Cost-effectiveness of Qvar Versus FP and BDP in the Management of COPD
Status: Completed Condition: Chronic Obstructive Pulmonary Disease

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813Mar 23, 2012RXYes5,776,432<disabled>Y<disabled>
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813Mar 23, 2012RXYes5,683,677<disabled>Y<disabled>
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813Mar 23, 2012RXYes5,605,674<disabled>Y<disabled>
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813Mar 23, 2012RXYes7,780,038<disabled>Y<disabled>
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813Mar 23, 2012RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc